JP2022548616A5 - - Google Patents
Info
- Publication number
- JP2022548616A5 JP2022548616A5 JP2022516406A JP2022516406A JP2022548616A5 JP 2022548616 A5 JP2022548616 A5 JP 2022548616A5 JP 2022516406 A JP2022516406 A JP 2022516406A JP 2022516406 A JP2022516406 A JP 2022516406A JP 2022548616 A5 JP2022548616 A5 JP 2022548616A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- pharmaceutical
- formulation
- risperidone
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025060885A JP2025106353A (ja) | 2019-09-13 | 2025-04-02 | 薬物送達製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962900061P | 2019-09-13 | 2019-09-13 | |
| US62/900,061 | 2019-09-13 | ||
| PCT/IB2020/058474 WO2021048817A1 (en) | 2019-09-13 | 2020-09-11 | Drug delivery formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025060885A Division JP2025106353A (ja) | 2019-09-13 | 2025-04-02 | 薬物送達製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022548616A JP2022548616A (ja) | 2022-11-21 |
| JP2022548616A5 true JP2022548616A5 (enExample) | 2024-01-05 |
| JP7661312B2 JP7661312B2 (ja) | 2025-04-14 |
Family
ID=72521677
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516406A Active JP7661312B2 (ja) | 2019-09-13 | 2020-09-11 | 薬物送達製剤 |
| JP2025060885A Pending JP2025106353A (ja) | 2019-09-13 | 2025-04-02 | 薬物送達製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025060885A Pending JP2025106353A (ja) | 2019-09-13 | 2025-04-02 | 薬物送達製剤 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US12383493B2 (enExample) |
| EP (2) | EP4027973B8 (enExample) |
| JP (2) | JP7661312B2 (enExample) |
| KR (1) | KR20220062372A (enExample) |
| CN (1) | CN114727946A (enExample) |
| AU (2) | AU2020346455B2 (enExample) |
| BR (1) | BR112022004535A2 (enExample) |
| CA (1) | CA3153793A1 (enExample) |
| DK (1) | DK4027973T3 (enExample) |
| ES (1) | ES3058225T3 (enExample) |
| FI (1) | FI4027973T3 (enExample) |
| HR (1) | HRP20251690T1 (enExample) |
| IL (1) | IL291283A (enExample) |
| LT (1) | LT4027973T (enExample) |
| MX (1) | MX2022003051A (enExample) |
| PL (1) | PL4027973T3 (enExample) |
| PT (1) | PT4027973T (enExample) |
| SI (1) | SI4027973T1 (enExample) |
| WO (1) | WO2021048817A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024511353A (ja) * | 2021-03-17 | 2024-03-13 | メドインセルル エス．エー． | リスペリドン及び生分解性ポリマーを含む長時間作用型注射用製剤 |
| JP2026501805A (ja) * | 2023-01-10 | 2026-01-16 | メドインセルル エス．エー． | オランザピン組成物及び使用の方法 |
| WO2026013080A1 (en) | 2024-07-08 | 2026-01-15 | InnoCore Technologies Holding B.V. | Pharmaceutical composition based on biodegradable polymers comprising polyoxazoline |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2299393A1 (en) | 1997-08-08 | 1999-02-18 | Sung Wan Kim | Injectable biodegradable block copolymer gels for use in drug delivery |
| CA2474968A1 (en) | 2002-01-31 | 2003-08-07 | Asahi Techno Glass Corporation | Cryopreservation medium for primate embryo stem cells and cryopreservation method |
| ES2562878T3 (es) | 2007-05-25 | 2016-03-08 | Indivior Uk Limited | Formulaciones de liberación sostenida de compuestos de risperidona |
| BRPI0919465A2 (pt) | 2008-09-30 | 2015-12-01 | Endo Pharmaceuticals Solutions | dispositivo implantável para a liberação de risperidona e métodos de uso do mesmo |
| CN101584652B (zh) | 2009-06-19 | 2012-06-20 | 上海医药集团股份有限公司 | 利培酮缓释凝胶注射剂及其制备方法 |
| US9023897B2 (en) | 2010-12-29 | 2015-05-05 | Medincell | Biodegradable drug delivery compositions |
| US20130144250A1 (en) * | 2011-10-24 | 2013-06-06 | Endo Pharmaceuticals Solutions Inc. | Implantable drug delivery compositions and methods of treatment thereof |
| EP2866837B1 (en) | 2012-06-27 | 2022-12-14 | Medincell S.A. | Biodegradable drug delivery for hydrophobic compositions |
| EA033537B1 (ru) | 2013-03-11 | 2019-10-31 | Durect Corp | Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью |
| EP3655017B1 (en) | 2017-07-17 | 2025-01-22 | Medincell S.A. | Pharmaceutical composition |
-
2020
- 2020-09-11 MX MX2022003051A patent/MX2022003051A/es unknown
- 2020-09-11 AU AU2020346455A patent/AU2020346455B2/en active Active
- 2020-09-11 JP JP2022516406A patent/JP7661312B2/ja active Active
- 2020-09-11 DK DK20772437.8T patent/DK4027973T3/da active
- 2020-09-11 CA CA3153793A patent/CA3153793A1/en active Pending
- 2020-09-11 EP EP20772437.8A patent/EP4027973B8/en active Active
- 2020-09-11 CN CN202080077874.0A patent/CN114727946A/zh active Pending
- 2020-09-11 FI FIEP20772437.8T patent/FI4027973T3/fi active
- 2020-09-11 EP EP25212808.7A patent/EP4706658A2/en active Pending
- 2020-09-11 ES ES20772437T patent/ES3058225T3/es active Active
- 2020-09-11 PT PT207724378T patent/PT4027973T/pt unknown
- 2020-09-11 US US17/642,410 patent/US12383493B2/en active Active
- 2020-09-11 LT LTEPPCT/IB2020/058474T patent/LT4027973T/lt unknown
- 2020-09-11 SI SI202030708T patent/SI4027973T1/sl unknown
- 2020-09-11 WO PCT/IB2020/058474 patent/WO2021048817A1/en not_active Ceased
- 2020-09-11 HR HRP20251690TT patent/HRP20251690T1/hr unknown
- 2020-09-11 KR KR1020227012200A patent/KR20220062372A/ko active Pending
- 2020-09-11 PL PL20772437.8T patent/PL4027973T3/pl unknown
- 2020-09-11 BR BR112022004535A patent/BR112022004535A2/pt unknown
-
2022
- 2022-03-10 IL IL291283A patent/IL291283A/en unknown
-
2023
- 2023-12-20 US US18/391,243 patent/US12128132B2/en active Active
-
2025
- 2025-04-02 JP JP2025060885A patent/JP2025106353A/ja active Pending
- 2025-05-12 US US19/205,563 patent/US20250268817A1/en active Pending
- 2025-09-30 AU AU2025242078A patent/AU2025242078A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2582395B1 (en) | Methods for the preparation of injectable depot compositions | |
| KR102189442B1 (ko) | 소수성 조성물용 생분해성 약물 전달 | |
| JP3133345B2 (ja) | Ｈｉｖに対して活性な連結環状ポリアミン | |
| CN103491946B (zh) | 可生物降解的药物释放组合物 | |
| JP2022548616A5 (enExample) | ||
| ZA202201465B (en) | Long-lasting formulation containing rivastigmine, and method for preparing same | |
| FI4027973T3 (fi) | Lääkkeensaattoformulaatioita | |
| JP2016527308A (ja) | エンテカビル微小球及びこれを含む非経口投与用医薬組成物 | |
| JP2007530693A (ja) | ６−メルカプトプリンの遅効性製剤 | |
| WO1998016252A1 (en) | New pharmaceutical parenteral formulation of a thrombin inhibitor | |
| JP2023533774A (ja) | ブプレノルフィンを送達するための親水性分解性マイクロスフェア | |
| CN108159049A (zh) | 一种吡啶类化合物的新用途 | |
| JP2024511353A5 (enExample) | ||
| US11872224B2 (en) | Amorphous solid dispersion formulation | |
| EA013569B1 (ru) | Фармацевтическая композиция рифабутина для лечения туберкулеза и заболеваний, опосредованных helicobacter pylori, способ ее получения и способ лечения | |
| WO2024220974A1 (en) | Rimegepant fast-dissolving films for oral administration | |
| JP2738979B2 (ja) | 非小細胞肺癌の治療 | |
| EP4164608A1 (en) | Pharmaceutical compositions | |
| JP7402806B2 (ja) | ４０－ｏ－環状炭化水素エステル及び関連構造のための非経口製剤材料及び方法 | |
| EA021117B1 (ru) | Способ получения водорастворимой фармацевтической композиции антибиотика из группы рифамицинов и фармацевтическая композиция для лечения туберкулеза и заболеваний, связанных с helicobacter pylori | |
| EP4203917A1 (en) | Injectable depot compositions for the delivery of antiviral agents | |
| US20230119275A1 (en) | Drug effective for lymphogenous drug administrating method | |
| CN108785249A (zh) | 含三苯双脒纳米超微粉的剂型 | |
| KR100791160B1 (ko) | 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물 | |
| CN101254169A (zh) | 含抗结核病药物的缓释剂 |